UNCY · CIK 0001766140 · FY2025 live · 2025-12-31
Unicycive Therapeutics, Inc.
View as
Model
Classic Z
FY2025
−3.93
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
20.82
0–100 · Classic Z tape · not a PD
Book standing
20
Year change
—
Market PD
—
O-score
23
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
−3.93
Z″ −6.84
Score −3.93 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.611.2 × = 0.73X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−2.601.4 × = −3.64X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.603.3 × = −1.98X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
1.590.6 × = 0.96X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Unicycive Therapeutics, Inc. is on classic Z at −3.93 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 35th percentile in Healthcare.
- DTILDistressPRECISION BIOSCIENCES INC−3.94
- LNSRDistressLENSAR, Inc.−3.98
- TNYADistressTenaya Therapeutics, Inc.−4.00
- TTRXDistressTurn Therapeutics Inc.−3.87
- BRNSDistressBarinthus Biotherapeutics plc.−4.02
- STIMDistressNeuronetics, Inc.−3.84
- PVLADistressPALVELLA THERAPEUTICS, INC.−3.83
- OBIODistressOrchestra BioMed Holdings, Inc.−4.04
KPI widgets
Current assets
$49M
Total assets
$49M
Current liabilities
$19M
Total liabilities
$19M
Working capital
$30M
Retained earnings
−$128M
EBIT
−$30M
Total sales
$0
Book equity
$30M
Accession 0001213900-26-035903. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.